![]() ![]() Much of that supply is coming from another contract manufacturer, Catalent Inc., which last week was authorized to make the shot at a facility in Bloomington, Indiana. government more than 20 million doses, and that it expects to deliver another 24 million by the end of April. New Brunswick, New Jersey-based J&J said it beat its March delivery target, providing the U.S. Representatives for Emergent declined to comment, deferring to J&J’s statement. The Biden administration has touted J&J’s one-dose, refrigerator-stored Covid shot as an efficient way to confer protection to Americans, particularly those in hard-to-reach places. It emerged on Wednesday that a batch of Johnson & Johnson vaccine was recently contaminated with AstraZeneca ingredients at the Emergent plant. Those vaccines require a two-dose regimen. and Moderna Inc., met their first quarter targets of 120 million doses and 100 million doses, respectively. The two other vaccine producers, Pfizer Inc. J&J, as of now, has produced by far the smallest supply of the U.S.-authorized Covid-19 vaccines. ![]() Manufacturing problems at the plant were first reported by the New York Times Wednesday. The company at the center of quality problems that led Johnson & Johnson to discard 15 million doses of its coronavirus vaccine has a string of citations from U.S. The statement added that the drugmaker addressed the issue with Emergent and reported it to the Food and Drug Administration. “This batch was never advanced to the filling and finishing stages of our manufacturing process.” ![]() “This quality control process identified one batch of drug substance that did not meet quality standards at Emergent BioSolutions, a site not yet authorized to manufacture drug substance for our Covid-19 vaccine,” J&J spokesman Jake Sargent said in an emailed statement. In a statement, J&J said a batch of drug substance failed its quality test. Subscribe to The Capsule, a weekly brief monitoring advances in health care and biopharma, delivered free to your inbox. There’s no safety fears with doses shipped, which came from other, authorized plants. Driving the news: The Baltimore Emergent BioSolutions manufacturing plant that ruined 15 million doses of the J&J vaccine had multiple procedural failures, including unsanitary conditions near sensitive manufacturing areas, per an FDA report released yesterday. have come from that plant, which isn’t authorized yet, two administration officials said, speaking on condition of anonymity. None of the doses produced and shipped so far in the U.S. Pauses Production of Its Covid Vaccine Despite Persistent Need A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has. will have enough vaccine for all adults in May, the people said. facility in Baltimore, isn’t expected to change President Joe Biden’s expectation that the U.S. The issue, which occurred recently at an Emergent BioSolutions Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |